HEMAVANT
DEAD

Serial Number

97842014

Owner

ROIVANT SCIENCES GMBH

Attorney

Joyce M. Ferraro

Filing Date

Mar 16, 2023

Add to watchlist:

No watchlists yet
View on USPTO

HEMAVANT Trademark

Serial Number: 97842014

HEMAVANT is a trademark filed by ROIVANT SCIENCES GMBH on March 16, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

ROIVANT SCIENCES GMBH (69 trademarks)

VIADUKTSTRASSE 8
BASEL 4051 , CH

Entity Type: 27

Trademark Details

Filing Date

March 16, 2023

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for human use for the treatment of hematological and bleeding diseases, disorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of hematological and bleeding diseases, disorders and conditions

Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions

Scientific and technological services, namely, medical research, scientific research and analysis in the field of hematology and bleeding diseases, disorders and conditions pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine; Conducting clinical trials for others relating to pharmaceutical preparations and biologic preparations; conducting post-authorization pharmaceutical research for use in the marketing of pharmaceutical preparations and biologic preparations and evaluating epidemiological results

Filing History

ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Aug 7, 2024 MAB1
ABANDONMENT - EXPRESS MAILED
Aug 7, 2024 ABN1
TEAS EXPRESS ABANDONMENT RECEIVED
Jul 30, 2024 EXAR
EXAMINER'S AMENDMENT ENTERED
Jul 30, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 30, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 30, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 30, 2024 CNEA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 16, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 16, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 17, 2023 GNFN
FINAL REFUSAL E-MAILED
Oct 17, 2023 GNFR
FINAL REFUSAL WRITTEN
Oct 17, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 18, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 18, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 29, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 29, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 29, 2023 CNRT
ASSIGNED TO EXAMINER
May 31, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 7, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 6, 2023 NWOS
NEW APPLICATION ENTERED
Mar 20, 2023 NWAP